Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population

Although etiologically heterogeneous at least 50% of all early on-set hearing losses have a genetic cause and of these, the large majority, 75-80% are most probably autosomal recessive and 70% are non-syndromic. The rest of the congenital hearing losses are determined by clinical and environmental f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental and therapeutic medicine 2021-06, Vol.21 (6), p.612, Article 612
Hauptverfasser: Neagu, Alexandra, Mocanu, Adela-Ioana, Bonciu, Alexandru, Coadă, Gabriella, Mocanu, Horia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 6
container_start_page 612
container_title Experimental and therapeutic medicine
container_volume 21
creator Neagu, Alexandra
Mocanu, Adela-Ioana
Bonciu, Alexandru
Coadă, Gabriella
Mocanu, Horia
description Although etiologically heterogeneous at least 50% of all early on-set hearing losses have a genetic cause and of these, the large majority, 75-80% are most probably autosomal recessive and 70% are non-syndromic. The rest of the congenital hearing losses are determined by clinical and environmental factors such as ototoxic medication, prematurity, and complications at birth. During the last decade it became clear that 50-80% of all such afflictions result from mutations in a single gene, , which encodes the protein Connexin 26. In order to, at least partially clarify this problem, especially in an emerging country such as Romania, where the problem is not studied adequately, we developed a comprehensive study of genetic, clinical and environmental risk factors for congenital hearing loss. The two most common variations of this gene, and in children with positive diagnosis of bilateral severe to profound sensorineural hearing loss were investigated. A cohort of 34 children (20 female and 14 male), ages between 2 and 10 (mean age 4.62 years), coming from 33 non-related families were evaluated. All cases were diagnosed with severe or profound bilateral congenital SNHL. A statistical comparison of genetic and environmental/clinical prevalence was also attempted since the presence of a genetic disorder cannot rule out the role of other documented risk factors in the etiology of SNHL. The results showed that, 29.4% of cases (10/34) were homozygotic for the mutation ), also known as genotype Δ/Δ. 5.88% of cases (2/34) belong to the heterozygotic bi-genic group . The clinical factors with high statistical significance for SNHL in a non-genetic group have no significance for genetic SNHL patients. Thus, the present study confirms the relatively high prevalence of the and mutations in cases of congenital non-syndromic severe of profound bilateral SNHL.
doi_str_mv 10.3892/etm.2021.10044
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8082587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A662836135</galeid><sourcerecordid>A662836135</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-a7d2726785edcb3dcfd3a4038f2abd3cc78b62fa0dc3a1d0a762e9291b40e89e3</originalsourceid><addsrcrecordid>eNptkstu1DAUhiMEolXpliWyxIbNDL7EibNBKlVpQZVACNaWY59kXBJ7sJOR-mS8Xk-Gabmo9sK37_z2Of6L4iWja6Ea_hamcc0pZ2tGaVk-KY5Z3fAVo0w-Pcxpo9hRcZrzDcUmK6aUfF4cCdGIilfNcfHrS4KdGSBYILEjl5_ec9JDADLOk5l8DJnYmBIMZgJHpki2CfI9bQcfvDUDMcERCDufYhghTLiTfP5BOmOnmDLxgUwbIIB6Q-xv96Ex4DV-QVEux-QDzAlXGzA478kQc17AJfBrHE3wJpBt3M7D_lkvimedGTKcHsaT4vuHi2_nV6vrz5cfz8-uV7ZkclqZ2vGaV7WS4GwrnO2cMCUVquOmdcLaWrUV7wx1VhjmqKkrDg1vWFtSUA2Ik-Ldb93t3I6ogdnhK_U2-dGkWx2N1_-eBL_RfdxpRRWXqkaBNweBFH_OkCc9-mxhGEyAOGfNJWeSlkJwRF__h97EOQVMb6FKxqgU7A_V47dpH7qI99pFVJ9VFVeiYkIitX6Ewu5g9Fh86DzuPxZgE1Y-QfeQI6N6cZtGt-nFbXrvNgx49XdlHvB7b4k7DijUWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2524110531</pqid></control><display><type>article</type><title>Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population</title><source>PubMed Central</source><creator>Neagu, Alexandra ; Mocanu, Adela-Ioana ; Bonciu, Alexandru ; Coadă, Gabriella ; Mocanu, Horia</creator><creatorcontrib>Neagu, Alexandra ; Mocanu, Adela-Ioana ; Bonciu, Alexandru ; Coadă, Gabriella ; Mocanu, Horia</creatorcontrib><description>Although etiologically heterogeneous at least 50% of all early on-set hearing losses have a genetic cause and of these, the large majority, 75-80% are most probably autosomal recessive and 70% are non-syndromic. The rest of the congenital hearing losses are determined by clinical and environmental factors such as ototoxic medication, prematurity, and complications at birth. During the last decade it became clear that 50-80% of all such afflictions result from mutations in a single gene, , which encodes the protein Connexin 26. In order to, at least partially clarify this problem, especially in an emerging country such as Romania, where the problem is not studied adequately, we developed a comprehensive study of genetic, clinical and environmental risk factors for congenital hearing loss. The two most common variations of this gene, and in children with positive diagnosis of bilateral severe to profound sensorineural hearing loss were investigated. A cohort of 34 children (20 female and 14 male), ages between 2 and 10 (mean age 4.62 years), coming from 33 non-related families were evaluated. All cases were diagnosed with severe or profound bilateral congenital SNHL. A statistical comparison of genetic and environmental/clinical prevalence was also attempted since the presence of a genetic disorder cannot rule out the role of other documented risk factors in the etiology of SNHL. The results showed that, 29.4% of cases (10/34) were homozygotic for the mutation ), also known as genotype Δ/Δ. 5.88% of cases (2/34) belong to the heterozygotic bi-genic group . The clinical factors with high statistical significance for SNHL in a non-genetic group have no significance for genetic SNHL patients. Thus, the present study confirms the relatively high prevalence of the and mutations in cases of congenital non-syndromic severe of profound bilateral SNHL.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2021.10044</identifier><identifier>PMID: 33936269</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Birth defects ; Deafness ; Environmental risk ; Enzymes ; Etiology ; Families &amp; family life ; Gene mutations ; Genes ; Genetic aspects ; Genotype &amp; phenotype ; Health aspects ; Hearing disorders in children ; Hearing loss ; Hypoxia ; Mutation ; Parents &amp; parenting ; Pediatric research ; Risk factors ; Statistical analysis ; Variables</subject><ispartof>Experimental and therapeutic medicine, 2021-06, Vol.21 (6), p.612, Article 612</ispartof><rights>Copyright © 2020, Spandidos Publications.</rights><rights>COPYRIGHT 2021 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2021</rights><rights>Copyright © 2020, Spandidos Publications 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-a7d2726785edcb3dcfd3a4038f2abd3cc78b62fa0dc3a1d0a762e9291b40e89e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082587/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082587/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33936269$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Neagu, Alexandra</creatorcontrib><creatorcontrib>Mocanu, Adela-Ioana</creatorcontrib><creatorcontrib>Bonciu, Alexandru</creatorcontrib><creatorcontrib>Coadă, Gabriella</creatorcontrib><creatorcontrib>Mocanu, Horia</creatorcontrib><title>Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population</title><title>Experimental and therapeutic medicine</title><addtitle>Exp Ther Med</addtitle><description>Although etiologically heterogeneous at least 50% of all early on-set hearing losses have a genetic cause and of these, the large majority, 75-80% are most probably autosomal recessive and 70% are non-syndromic. The rest of the congenital hearing losses are determined by clinical and environmental factors such as ototoxic medication, prematurity, and complications at birth. During the last decade it became clear that 50-80% of all such afflictions result from mutations in a single gene, , which encodes the protein Connexin 26. In order to, at least partially clarify this problem, especially in an emerging country such as Romania, where the problem is not studied adequately, we developed a comprehensive study of genetic, clinical and environmental risk factors for congenital hearing loss. The two most common variations of this gene, and in children with positive diagnosis of bilateral severe to profound sensorineural hearing loss were investigated. A cohort of 34 children (20 female and 14 male), ages between 2 and 10 (mean age 4.62 years), coming from 33 non-related families were evaluated. All cases were diagnosed with severe or profound bilateral congenital SNHL. A statistical comparison of genetic and environmental/clinical prevalence was also attempted since the presence of a genetic disorder cannot rule out the role of other documented risk factors in the etiology of SNHL. The results showed that, 29.4% of cases (10/34) were homozygotic for the mutation ), also known as genotype Δ/Δ. 5.88% of cases (2/34) belong to the heterozygotic bi-genic group . The clinical factors with high statistical significance for SNHL in a non-genetic group have no significance for genetic SNHL patients. Thus, the present study confirms the relatively high prevalence of the and mutations in cases of congenital non-syndromic severe of profound bilateral SNHL.</description><subject>Birth defects</subject><subject>Deafness</subject><subject>Environmental risk</subject><subject>Enzymes</subject><subject>Etiology</subject><subject>Families &amp; family life</subject><subject>Gene mutations</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Genotype &amp; phenotype</subject><subject>Health aspects</subject><subject>Hearing disorders in children</subject><subject>Hearing loss</subject><subject>Hypoxia</subject><subject>Mutation</subject><subject>Parents &amp; parenting</subject><subject>Pediatric research</subject><subject>Risk factors</subject><subject>Statistical analysis</subject><subject>Variables</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkstu1DAUhiMEolXpliWyxIbNDL7EibNBKlVpQZVACNaWY59kXBJ7sJOR-mS8Xk-Gabmo9sK37_z2Of6L4iWja6Ea_hamcc0pZ2tGaVk-KY5Z3fAVo0w-Pcxpo9hRcZrzDcUmK6aUfF4cCdGIilfNcfHrS4KdGSBYILEjl5_ec9JDADLOk5l8DJnYmBIMZgJHpki2CfI9bQcfvDUDMcERCDufYhghTLiTfP5BOmOnmDLxgUwbIIB6Q-xv96Ex4DV-QVEux-QDzAlXGzA478kQc17AJfBrHE3wJpBt3M7D_lkvimedGTKcHsaT4vuHi2_nV6vrz5cfz8-uV7ZkclqZ2vGaV7WS4GwrnO2cMCUVquOmdcLaWrUV7wx1VhjmqKkrDg1vWFtSUA2Ik-Ldb93t3I6ogdnhK_U2-dGkWx2N1_-eBL_RfdxpRRWXqkaBNweBFH_OkCc9-mxhGEyAOGfNJWeSlkJwRF__h97EOQVMb6FKxqgU7A_V47dpH7qI99pFVJ9VFVeiYkIitX6Ewu5g9Fh86DzuPxZgE1Y-QfeQI6N6cZtGt-nFbXrvNgx49XdlHvB7b4k7DijUWA</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Neagu, Alexandra</creator><creator>Mocanu, Adela-Ioana</creator><creator>Bonciu, Alexandru</creator><creator>Coadă, Gabriella</creator><creator>Mocanu, Horia</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210601</creationdate><title>Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population</title><author>Neagu, Alexandra ; Mocanu, Adela-Ioana ; Bonciu, Alexandru ; Coadă, Gabriella ; Mocanu, Horia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-a7d2726785edcb3dcfd3a4038f2abd3cc78b62fa0dc3a1d0a762e9291b40e89e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Birth defects</topic><topic>Deafness</topic><topic>Environmental risk</topic><topic>Enzymes</topic><topic>Etiology</topic><topic>Families &amp; family life</topic><topic>Gene mutations</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Genotype &amp; phenotype</topic><topic>Health aspects</topic><topic>Hearing disorders in children</topic><topic>Hearing loss</topic><topic>Hypoxia</topic><topic>Mutation</topic><topic>Parents &amp; parenting</topic><topic>Pediatric research</topic><topic>Risk factors</topic><topic>Statistical analysis</topic><topic>Variables</topic><toplevel>online_resources</toplevel><creatorcontrib>Neagu, Alexandra</creatorcontrib><creatorcontrib>Mocanu, Adela-Ioana</creatorcontrib><creatorcontrib>Bonciu, Alexandru</creatorcontrib><creatorcontrib>Coadă, Gabriella</creatorcontrib><creatorcontrib>Mocanu, Horia</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Neagu, Alexandra</au><au>Mocanu, Adela-Ioana</au><au>Bonciu, Alexandru</au><au>Coadă, Gabriella</au><au>Mocanu, Horia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Exp Ther Med</addtitle><date>2021-06-01</date><risdate>2021</risdate><volume>21</volume><issue>6</issue><spage>612</spage><pages>612-</pages><artnum>612</artnum><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>Although etiologically heterogeneous at least 50% of all early on-set hearing losses have a genetic cause and of these, the large majority, 75-80% are most probably autosomal recessive and 70% are non-syndromic. The rest of the congenital hearing losses are determined by clinical and environmental factors such as ototoxic medication, prematurity, and complications at birth. During the last decade it became clear that 50-80% of all such afflictions result from mutations in a single gene, , which encodes the protein Connexin 26. In order to, at least partially clarify this problem, especially in an emerging country such as Romania, where the problem is not studied adequately, we developed a comprehensive study of genetic, clinical and environmental risk factors for congenital hearing loss. The two most common variations of this gene, and in children with positive diagnosis of bilateral severe to profound sensorineural hearing loss were investigated. A cohort of 34 children (20 female and 14 male), ages between 2 and 10 (mean age 4.62 years), coming from 33 non-related families were evaluated. All cases were diagnosed with severe or profound bilateral congenital SNHL. A statistical comparison of genetic and environmental/clinical prevalence was also attempted since the presence of a genetic disorder cannot rule out the role of other documented risk factors in the etiology of SNHL. The results showed that, 29.4% of cases (10/34) were homozygotic for the mutation ), also known as genotype Δ/Δ. 5.88% of cases (2/34) belong to the heterozygotic bi-genic group . The clinical factors with high statistical significance for SNHL in a non-genetic group have no significance for genetic SNHL patients. Thus, the present study confirms the relatively high prevalence of the and mutations in cases of congenital non-syndromic severe of profound bilateral SNHL.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>33936269</pmid><doi>10.3892/etm.2021.10044</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1792-0981
ispartof Experimental and therapeutic medicine, 2021-06, Vol.21 (6), p.612, Article 612
issn 1792-0981
1792-1015
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8082587
source PubMed Central
subjects Birth defects
Deafness
Environmental risk
Enzymes
Etiology
Families & family life
Gene mutations
Genes
Genetic aspects
Genotype & phenotype
Health aspects
Hearing disorders in children
Hearing loss
Hypoxia
Mutation
Parents & parenting
Pediatric research
Risk factors
Statistical analysis
Variables
title Prevalence of GJB2 gene mutations correlated to presence of clinical and environmental risk factors in the etiology of congenital sensorineural hearing loss of the Romanian population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T13%3A49%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20GJB2%20gene%20mutations%20correlated%20to%20presence%20of%20clinical%20and%20environmental%20risk%20factors%20in%20the%20etiology%20of%20congenital%20sensorineural%20hearing%20loss%20of%20the%20Romanian%20population&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Neagu,%20Alexandra&rft.date=2021-06-01&rft.volume=21&rft.issue=6&rft.spage=612&rft.pages=612-&rft.artnum=612&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2021.10044&rft_dat=%3Cgale_pubme%3EA662836135%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2524110531&rft_id=info:pmid/33936269&rft_galeid=A662836135&rfr_iscdi=true